[1]Xie P, Liu K, Peng W, et al. The correlation between diffusion-weighted imaging at 3.0T magnetic resonance imaging and histopathology for pancreatic ductal adenocarcinoma [J]. J Comp Assist Tomogr, 2015, 39: 697-701. [2]Matthias B, Bachir T, Boris G, et al. Diffusion-weighted MR imaging of the pancreas: current status and recommendations [J]. Radiol,2015, 274: 45-63. [3]秦青,任刚,李晶,等.高剂量少分次放疗模式治疗胰腺癌对患者生活质量的影响[J].中华放射肿瘤学杂志,2018,27:656-660. [4]Wang Y, Chen ZE, Nikolaidis P, et al. Diffusion-weighted magnetic resonance imaging of pancreatic adenocarcinomas: association with histopathology and tumor grade [J].J Mag Reson Imaging, 2011,33:136-142. [5]郝利国,崔红升,孟鑫,等.磁共振功能成像DWI技术在家兔胰腺肿物模型鉴别中的应用价值[J].重庆医学,2017,46:3375-3377. [6]王维青,武霞,伏宝成,等.多模态MRI在宫颈癌放疗后疗效评估中的价值[J].中国临床医学影像杂志,2017,28:872-876. [7]秦丹,王萍,时惠平,等.3.0T MR多b值DWI序列评价胰腺癌放疗疗效[J].中国医学影像技术,2015,31:576-580. [8]宋琦,刘玉,胡曙东,等.磁共振弥散加权成像在125I粒子组织间植入治疗胰腺癌疗效评估中的应用[J].介入放射学杂志,2012,21:492-497. [9]De Cobelli F,Giganti F,Orsenigo E, et al. Apparent diffusion coefficient modifications in assessing gastro-esophageal cancer response to neoadjuvant treatment:comparison with tumor regression grade at histology [J]. Euro Radiol,2013,23:2165-2174. [10]Cui Y, Zhang XP, Sun YS, et al. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases [J]. Radiology,2008,248:894-900. [11]陈伟,周胜利,苗重昌,等.DWI在食管癌同期放化疗早期疗效评价中的初步研究[J].中华放射肿瘤学杂志,2014,23:312-316. [12]Ma WL,Li N,Zhao WW,et al. Apparent diffusion coefficient and dynamic contrast-enhanced magnetic resonance imaging in pancreatic cancer: characteristics and correlation with histopathologic parameters [J]. J Comp Assist Tomogr,2016, 40: 709-716. |